Predicting PICO requirements can help pharmaceutical manufacturers anticipate the populations, comparators and outcomes that may shape future health technology assessments (HTAs). However, prediction alone is not enough. Understanding where evidence is strong, where uncertainty remains and how these findings influence strategic decisions is essential to effective evidence planning and market access preparation.
In this on-demand webinar, Remap’s Ashley Humphries and Gillian Nicol explore how manufacturers can translate PICO predictions into actionable insights to inform wider market access strategy.
Access the Recording
What the session covers
- How to tailor PICO prediction approaches to different assets, development stages and strategic objectives
- Practical considerations for managing uncertainty and validating predicted PICO requirements
- How to prioritise PICO evidence gaps and determine appropriate evidence-generation responses
- Opportunities to apply PICO frameworks beyond JCA to inform wider evidence and market access strategy